Resveratrol modulates astroglial functions: Neuroprotective hypothesis

Annals of the New York Academy of Sciences

Volumn 1215, Issue 1, 2011, Pages 72-78

  Quincozes Santos, André ^a   Gottfried, Carmem ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Astrocytes; Glutamatergic metabolism; Neuroprotective; Oxidative stress; Resveratrol

Indexed keywords

GLUTAMATE AMMONIA LIGASE; GLUTAMIC ACID; GLUTATHIONE; RESVERATROL;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTROCYTE; CELL FUNCTION; CHEMOPROPHYLAXIS; ENZYME ACTIVITY; HEART PROTECTION; HUMAN; NERVE CELL PLASTICITY; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS;

VITACEAE;

EID: 78851472360     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2010.05857.x     Document Type: Article

References (68)

1. Joseph, J. et al 2009. Nutrition, brain aging, and neurodegeneration. J. Neurosci. 29: 12795-12801.
2. Xia, E.Q. et al 2010. Biological activities of polyphenols from grapes. Int. J. Mol. Sci. 11: 622-646.
3. Halliwell, B. 2007. Dietary polyphenols: good, bad, or indifferent for your health? Cardiovasc. Res. 73: 341-347.
4. Nonomura, S., H. Kanagawa & A. Makimoto 1963. [Chemical Constituents of Polygonaceous Plants. I. Studies on the Components of Ko-J O-Kon. (Polygonum Cuspidatum Sieb. Et Zucc.)]. Yakugaku Zasshi. 83: 988-990.
5. Pervaiz, S. 2003. Resveratrol: from grapevines to mammalian biology. FASEB J. 17: 1975-1985.
6. Fremont, L. 2000. Biological effects of resveratrol. Life Sci. 66: 663-673.
7. Johnson, H. 2004. In The Story of Wine. Mitchell Beazley Publishers, Ed. Octopus Publishing Group. London, UK.
8. Renaud, S. & M. de Lorgeril 1992. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 339: 1523-1526.
9. Dore, S. 2005. Unique properties of polyphenol stilbenes in the brain: more than direct antioxidant actions; gene/protein regulatory activity. Neurosignals 14: 61-70.
10. Soleas, G.J., E.P. Diamandis & D.M. Goldberg 1997. Resveratrol: a molecule whose time has come? And gone? Clin. Biochem. 30: 91-113.
11. Souto, A.A. et al 2001. Determination of trans-resveratrol concentrations in Brazilian red wines by HPLC. J. Food Compos. Anal. 14: 441-445.
12. Delmas, D., B. Jannin & N. Latruffe 2005. Resveratrol: preventing properties against vascular alterations and ageing. Mol. Nutr. Food Res. 49: 377-395.
13. Baur, J.A. & D.A. Sinclair 2006. Therapeutic potential of resveratrol: the in vivo evidence. Nat. Rev. Drug Discov. 5: 493-506.
14. Das, S. & D.K. Das 2007. Anti-inflammatory responses of resveratrol. Inflamm Allergy Drug Targets. 6: 168-173.
15. Dudley, J. et al 2009. Resveratrol, a unique phytoalexin present in red wine, delivers either survival signal or death signal to the ischemic myocardium depending on dose. J. Nutr. Biochem. 20: 443-452.
16. Baur, J.A. 2010. Resveratrol, sirtuins, and the promise of a DR mimetic. Mech. Ageing Dev. 131: 261-269.
17. Albani, D., L. Polito & G. Forloni 2009. Sirtuins as novel targets for Alzheimer's disease and other neurodegenerative disorders: experimental and genetic evidence. J. Alzheimers Dis. 19: 11-26.
18. Baur, J.A. et al 2006. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444: 337-342.
19. Sarkar, F.H. et al 2009. Cellular signaling perturbation by natural products. Cell Signal 21: 1541-1547.
20. Della-Morte, D. et al 2009. Resveratrol pretreatment protects rat brain from cerebral ischemic damage via a sirtuin 1-uncoupling protein 2 pathway. Neuroscience 159: 993-1002.
21. Jang, M. et al 1997. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275: 218-220.
22. Virgili, M. & A. Contestabile 2000. Partial neuroprotection of in vivo excitotoxic brain damage by chronic administration of the red wine antioxidant agent, trans-resveratrol in rats. Neurosci. Lett. 281: 123-126.
23. de la Lastra, C.A. & I. Villegas 2007. Resveratrol as an antioxidant and pro-oxidant agent: mechanisms and clinical implications. Biochem. Soc. Trans. 35: 1156-1160.
24. Halliwell, B. 2006. Oxidative stress and neurodegeneration: where are we now? J. Neurochem. 97: 1634-1658.
25. Dringen, R., P.G. Pawlowski & J. Hirrlinger 2005. Peroxide detoxification by brain cells. J. Neurosci. Res. 79: 157-165.
26. Hyslop, P.A. et al 1995. Measurement of striatal H2O2 by microdialysis following global forebrain ischemia and reperfusion in the rat: correlation with the cytotoxic potential of H2O2 in vitro. Brain Res. 671: 181-186.
27. Magistretti, P.J. 2006. Neuron-glia metabolic coupling and plasticity. J. Exp. Biol. 209: 2304-2311.
28. Araque, A. 2008. Astrocytes process synaptic information. Neuron. Glia Biol. 4: 3-10.
29. Araque, A., G. Carmignoto & P.G. Haydon 2001. Dynamic signaling between astrocytes and neurons. Annu. Rev. Physiol. 63: 795-813.
30. Nishiyama, H. et al 2002. Glial protein S100B modulates long-term neuronal synaptic plasticity. Proc. Natl. Acad. Sci. USA 99: 4037-4042.
31. Perea, G. & A. Araque 2009. GLIA modulates synaptic transmission. Brain Res. Rev. 63: 93-102.
32. Salmina, A.B. 2009. Neuron-glia interactions as therapeutic targets in neurodegeneration. J. Alzheimers Dis. 16: 485-502.
33. Wang, D.D. & A. Bordey 2008. The astrocyte odyssey. Prog. Neurobiol. 86: 342-367.
34. Markiewicz, I. & B. Lukomska 2006. The role of astrocytes in the physiology and pathology of the central nervous system. Acta Neurobiol. Exp. (Wars) 66: 343-358.
35. Schulz, J.B. et al 2000. Glutathione, oxidative stress and neurodegeneration. Eur. J. Biochem. 267: 4904-4911.
36. Quincozes-Santos, A. et al 2007. Resveratrol attenuates oxidative-induced DNA damage in C6 Glioma cells. Neurotoxicology 28: 886-891.
37. Van Eldik, L.J. & D.B. Zimmer 1987. Secretion of S-100 from rat C6 glioma cells. Brain Res. 436: 367-370.
38. Quincozes-Santos, A. et al 2009. The janus face of resveratrol in astroglial cells. Neurotox. Res. 16: 30-41.
39. Cechin, S.R., P.R. Dunkley & R. Rodnight 2005. Signal transduction mechanisms involved in the proliferation of C6 glioma cells induced by lysophosphatidic acid. Neurochem. Res. 30: 603-611.
40. Desagher, S., J. Glowinski & J. Premont 1996. Astrocytes protect neurons from hydrogen peroxide toxicity. J. Neurosci. 16: 2553-2562.
41. Aksenova, M.V. et al 2005. Cell culture models of oxidative stress and injury in the central nervous system. Curr. Neurovasc. Res. 2: 73-89.
42. Danbolt, N.C. 2001. Glutamate uptake. Prog. Neurobiol. 65: 1-105.
43. Hertz, L. 2006. Glutamate, a neurotransmitter-and so much more. A synopsis of Wierzba III. Neurochem. Int. 48: 416-425.
44. Mates, J. M. et al 2002. Glutamine and its relationship with intracellular redox status, oxidative stress and cell proliferation/death. Int. J. Biochem. Cell Biol. 34: 439-458.
45. Araque, A. et al 1999. Tripartite synapses: glia, the unacknowledged partner. Trends Neurosci. 22: 208-215.
46. Banerjee, R., V. Vitvitsky & S.K. Garg 2008. The undertow of sulfur metabolism on glutamatergic neurotransmission. Trends Biochem. Sci. 33: 413-419.
47. Marino, M.J. & P.J. Conn 2006. Glutamate-based therapeutic approaches: allosteric modulators of metabotropic glutamate receptors. Curr. Opin. Pharmacol. 6: 98-102.
48. dos Santos, A.Q. et al 2006. Resveratrol increases glutamate uptake and glutamine synthetase activity in C6 glioma cells. Arch. Biochem. Biophys. 453: 161-167.
49. de Almeida, L.M. et al 2007. Resveratrol increases glutamate uptake, glutathione content, and S100B secretion in cortical astrocyte cultures. Cell. Mol. Neurobiol. 27: 661-668.
50. 2 in acute hippocampal slice preparations from Wistar rats. Arch. Biochem. Biophys. 480: 27-32.
51. Vieira de Almeida, L.M. et al 2008. Protective effects of resveratrol on hydrogen peroxide induced toxicity in primary cortical astrocyte cultures. Neurochem. Res. 33: 8-15.
52. Kouda, K. & M. Iki 2010. Beneficial effects of mild stress (hormetic effects): dietary restriction and health. J. Physiol. Anthropol. 29: 127-132.
53. Day, R.M. & Y.J. Suzuki 2005. Cell proliferation, reactive oxygen and cellular glutathione. Dose Response 3: 425-442.
54. Kendig, E.L., H.H. Le & S.M. Belcher 2010. Defining hormesis: evaluation of a complex concentration response phenomenon. Int. J. Toxicol. 29: 235-246.
55. Coyle, J.T. & P. Puttfarcken 1993. Oxidative stress, glutamate, and neurodegenerative disorders. Science 262: 689-695.
56. Trotti, D., N.C. Danbolt & A. Volterra 1998. Glutamate transporters are oxidant-vulnerable: a molecular link between oxidative and excitotoxic neurodegeneration? Trends Pharmacol. Sci. 19: 328-334.
57. Zamin, L.L. et al 2006. Protective effect of resveratrol against oxygen-glucose deprivation in organotypic hippocampal slice cultures: involvement of PI3-K pathway. Neurobiol. Dis. 24: 170-182.
58. Benjamin, A.M. & J.H. Quastel 1975. Metabolism of amino acids and ammonia in rat brain cortex slices in vitro: a possible role of ammonia in brain function. J. Neurochem. 25: 197-206.
59. Westergaard, N., U. Sonnewald & A. Schousboe 1995. Metabolic trafficking between neurons and astrocytes: the glutamate/glutamine cycle revisited. Dev. Neurosci. 17: 203-211.
60. Pope, S.A., R. Milton & S.J. Heales 2008. Astrocytes protect against copper-catalysed loss of extracellular glutathione. Neurochem. Res. 33: 1410-1418.
61. Halliwell, B. & M. Whiteman 2004. Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean? Br. J. Pharmacol. 142: 231-255.
62. McKenna, M.C. 2007. The glutamate-glutamine cycle is not stoichiometric: fates of glutamate in brain. J. Neurosci. Res. 85: 3347-3358.
63. Hertz, L. & H.R. Zielke 2004. Astrocytic control of glutamatergic activity: astrocytes as stars of the show. Trends Neurosci. 27: 735-743.
64. Sharma, M. & Y.K. Gupta 2002. Chronic treatment with trans resveratrol prevents intracerebroventricular streptozotocin induced cognitive impairment and oxidative stress in rats. Life Sci. 71: 2489-2498.
65. Donato, R. et al 2009. S100B's double life: intracellular regulator and extracellular signal. Biochim. Biophys. Acta 1793: 1008-1022.
66. Donato, R. 2001. S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int. J. Biochem. Cell Biol. 33: 637-668.
67. Donato, R. et al 2009. S100B's double life: Intracellular regulator and extracellular signal. Biochim. Biophys. Acta 1793: 797-811.
68. Goncalves, C.A., M. Concli Leite & P. Nardin 2008. Biological and methodological features of the measurement of S100B, a putative marker of brain injury. Clin Biochem. 41: 755-763.